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Relevance of Animal Experiments to
Humans
by David P. RaIl*
The best evidence ofan adverse human health effect is a properly conducted epidemiological study. But
human beingsshould not be the sole test animal. Properly conducted animal studies have been shown to be
predictive for carcinogenicity and toxicologic responses in human populations. We need to develop more
efficient predictive animal tests for all the common serious toxic effects caused by chemicals.
One particularly important use ofepidemiolgical studies is to validate (or invalidate) the laboratory
animal experiments. There is no more powerful tool than the combination of well conducted animal
experiments and well conducted epidemiobgical experiments.
The whole issue of the relevance ofthe results of
laboratory animal toxicology studies to the human
experience is adifficult, yet important problem. It is
even moredifficultwhen one looks atit inthe lightof
our nation's need for energy from coal. Shy has
described most eloquently the complex problems of
extracting, transporting, and combusting an intrinsi-
cally dirty material like coal (1). There are hundreds
of potentially toxic compounds involved, although
the ones that we think about most commonly in
terms of air pollutants affecting the general popula-
tion are SO, and NO,, the trace and heavy metals,
oxidants, particulates, etc. There are, in addition,
the large number of benzpyrene type compounds
which are likely to be hazardous. We also must be
concernedaboutsynergistic effects with such alarge
mixture of compounds. The art and science of pre-
dicting synergistic toxic effects of two or more
compounds and extrapolating such effects from lab-
oratory animal systems to human populations is
primitive. Let me note the studies by Laskin and the
New York University group (2) in which concen-
trations of benzpyrene that do not normally cause
broncogenic carcinoma in rats will cause bronco-
genic carcinoma with the addition of inhaled S02.
This may be true for the general population, and be
the cause ofthe "urban factor" which increases the
incidence of lung cancer.
We are dealing here with large human populations
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andwithrelatively smalldifferences inexposure. We
must ask: Where do we go from here? Can we use
experiments with laboratory animals to project what
is likely to happen in the human population?
The first thing we ought to do is look at the data.
The relatively few data that exist which bear on this
particular and critically important problem, I am
sorry to say, are not very new. I was involved in a
study more yearsagothan Iwould liketodiscussthat
looked at anticancer drugs in terms oftheir toxicity
to humans and their toxicity to laboratory animals
(4). This may seem to be an unusual topic to bring up
at this meeting. There were unique advantages of
using this class ofcompounds for this kind ofstudy.
Excellent human toxicology studies were available,
something that is almost unheard of in any sort of
study. Because to be effective these drugs had to be
given in dosages that caused rather clear-cut human
effects, fairly clear-cut answers were available as to
how toxic they were in the patients that were being
studied. There were few moral and ethical issues
because these were therapeutic agents and they of-
fered hope, in some cases very real hope, ofbenefit
forthe patients in this study. In fact, we determined
what clinical data were available before we went
back to design and perform the animal studies.
It may be expensive to do toxicology studies in
animals, but it is much less expensive than doing
human clinical trials. The animal studies were de-
signed to mimic as closely as possible the studies we
knew were available from the clinic. The route of
administration, the dose schedules, and so forth
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The quantitative aspects of comparative car-
cinogenicity is a much more difficult question. An *tabllt@in ogenNASINRC group on current pest control practices tl/ogents did look for the first time at quantitative aspects of
carcinogenicity in human populations and in labo-
_ *-i. ratory animal studies (7). The human data were the
best available, but certainly less than desired. The
A animal data were also of variable quality. In com-
paring animal and human responses, they used the
responses from the most sensitive animal species.
A With respect to benzidine the predicted human inci-
dence was about the same as what was seen in the
most susceptible animal species. This was also true
7_____ /with chlornaphthazine and with cigarette smoke.
The geographic studies which link aflatoxin ex-
posure to liver cancer suggest about a tenfold lower
incidence than would have been predicted by the
_______ most susceptible animal species. For the other two
1.0 10 100 1000 compounds, diethylstilbestrol and vinyl chloride,
BFDI MOUSE; LDIo the human populations are still at risk, and now it
MG/M2; OD 1-5 DAY SCHEDULE) looks like the most sensitive animal species has ex-
ip between toxicity of anticancer drugs in aggerated the risk to man. Since these populations
irine and human species. are still at risk, the human incidence may increase in
the future.
were as close as possible. The results are easily
summarized in Figure 1. Here are plotted the LD,o'
levels in one mouse strain against the maximum tol-
erated dose in the human patients for about 23 com-
pounds. There was a fourfold log range of intrinsic
toxicitiesforthe23compounds. Thepointsclustered
very closely around a line with a 45 degree slope,
suggesting there is a good relationship between
quantitative toxicity in the mouse and in manforthe
toxic effects caused by these chemicals.
There are perhaps even fewer clear-cut examples
tooofcarcinogenesis data. Table 1 shows the chemi-
cals that expert groups at the International Associa-
tion for Research on Cancer (IRC) in Lyon, France,
decided can be considered to be carcinogenic in man
(5). There is as yet no clear-cut evidence in the labo-
ratory animal studies that arsenic and benzene are
carcinogenic. I believe that neither of these com-
pounds has been adequately studied. However,
there is a study by Maltoni (6) suggesting a car-
cinogenic effect for benzene and an inhalation study
at New York University (7) which shows leukemias
after benzene exposure. Three other compounds,
chloramphenicol, oxymetholone, and phenacetin,
have not been adequately studied in animals; but for
the others there is a very good qualitative relation-
ship. These compounds which are carcinogenic in
human populations are also carcinogenic in labora-
tory animals. There is reasonably close agreement
between the laboratory animals and the human
population.
I am convinced that there is a good degree of
association between the most sensitive animal
species and the human population. I would pause to
say that these data obtained after humans had inad-
vertently been exposed to carcinogens must be
among the most precious data we have in the
biomedical community. We must always be on the
lookout for such data so that we may learn as much
as we can from it.
Cancer, ofcourse, is not the only problem, as we
all know. More people die of cardiovascular prob-
lems. Chronic respiratory disease is one ofthe most
rapidly increasing causes ofmorbidity in the United
States today (8). We are seeing more and more evi-
dences ofreproductive toxicology and chronic liver
and kidney disease. We do not have the datato form
any conclusions about how well animal studies pre-
Table 1.
Predicted human incidence
based on most sensitive animal
species relative to epidemiologi-
cal studies
Benzidine the same as
Chlornaphthazine the same as
Cigarette smoke the same as
Aflatoxin Bi 10 x greater than
DES 50 x greater thana
Vinyl chloride 500 x greater thana
aPopulation still at risk.
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icologists study. I can phrase this conclusion one of
two ways: I could say we have little evidence that
animals do not predict for man - and that is a per-
fectlyreasonable statement. OrIcould saythatthere
is little evidence that animals do predict for man
and that is a reasonable statement. Itjust depends.
The proper statement is that there is little evidence
one way or the other. This tells us we must focus
major research efforts within the scientific commu-
nity on obtaining answers to these problems.
As I have observed the scientific community over
the years I find itconvenient to divide scientists into
what I call lumpers and splinters. Lumpers and
splinters are each very important to successful sci-
entific endeavor, and I do not mean to come out
anti-lumper or anti-splinter. But lumpers say: Let's
look at the aggregate; let's try to put together all the
dataand see ifwe candiscern some sort ofapattern.
Do we see similarities or do we see only discon-
tinuities? The typical species we use for toxicology
studies are mice, rats, and dogs. These species have
coexistedwithmanformanygenerations. They have
shared our bed and board for literally millions of
years and they still do. Perhaps it is not surprising
that we see some similarities in responses to toxic
agents from these mammalian friends of ours that
have lived with us for so very long. Splinters, on the
other hand, dissect every example, every report of
species differences, to try to determine what they
can learn, what different mechanisms are used by
species that respond differently to accomplish the
same basic physiological function. These analytical
studies are of immense importance to biomedical
science. But when we look for broad guiding princi-
ples, it seems to me the lumpers are the more impor-
tant. When we look at the aggregated science in this
way, it seems to me that laboratory animals do pre-
dictforhumantoxicological endpoints. They predict
well, but they do not predict perfectly. There is
nothing that I know in the biological sciences that is
perfect.
What then ofepidemiological studies? Now there
aremany instanceswhenonlybroadepidemiological
studies can give the needed information. The at-
tempts to determine whether the ambient levels of
common airpollutants do have anyeffects on human
health must use this sort of broad-scale epidemi-
ological studies. These studies take a long time be-
cause chronic effects may take at least a generation
toappear. Thus, we are faced withthe exposure ofa
population for at least a generation before an
epidemiological study can clearly relate chemical
exposure to the toxicological endpoint. They can be
very insensitive when there are small differences
between exposed and unexposed groups or when
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Table 2. Hexachlorobenzene in Louisiana cattle.
Projected losses
Direct 4550 cattle
($2,275,000)
Transactional (unestimated)
Actual losses
Direct 3 cattle
($1,500)
Transactional ($380,000)
essentially all populations exposed with only some
gradation between highly and less highly exposed.
But clearly they are needed.
One particularly important use ofepidemiological
studies is to validate (or invalidate) the laboratory
animal experiments. There is no more powerful tool
than the combination of well conducted animal ex-
periments and well conducted epidemiological ex-
periments.
What are our needs? Our needs, I think, are to
develop more efficient predictive animal tests for all
the common serious toxic effects caused by chemi-
cals. We must be alert to any opportunity to test the
hypothesis that a chemical does cause toxicity in
man when we are given the opportunity inadver-
tently. We certainly need to have more dialogue to
develop something closerto aconcensus on the rela-
vancy of animal testing.
Before Iclose, I would like tocommenton current
efforts to look at costs and benefits of various gov-
ernmental regulatory actions that relate to health.
The benefits are presumably the reduction in the
burden of disease. This is done in the biomedical
community by attempting to match animal ex-
perimentswithepidemiological data. Wepublish our
hypotheses; these are criticized; we go back to the
drawing board; we look for other test systems. We
have an iterative system that tries to determine the
precision of our estimates of human toxicity based
on either animal orepidemiological evidence. I sub-
mitwe do it pretty well. But let me suggest that I am
concerned about the precision of some of the cost
estimates in this process. Table 2 depicts one ex-
ample of a cost estimate developed by David
Dominick when he was in the Environmental Pro-
tection Agency (EPA) (9). The issue was hexa-
chlorobenzene inLouisanacattle. Thiseffluentfrom
a plastics manufacturer contaminated the fields in
which the cattle grazed. The cattle were found to
have a significant body burden of hexachloroben-
zene. EPA picked an action or tolerance level (typi-
cally on the basis of inadequate information, since
that is about where we are with most chemicals).
EPAthencarefully projected losses (costs) resulting
from this regulatory action.
299It was estimated that 4550 cattle, worth well over
$2million, would have to be destroyed. What David
Dominick did was to go back to Louisiana after the
whole episode was over and try to determine how
many cattle were destroyed. It turned out that three
head of cattle were destroyed at a cost of about
$1500. Much ofthe same thing happened withregard
toestimatedcompliancecostsandactualcompliance
costs for the workplace standard of 1 ppm for vinyl
chloride. I wonder whether the precision of proj-
ected costs is inthe same ballpark asthe precision of
predicted health effects based on animal extrapola-
tion and clinical studies.
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